Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) is a publicly traded Healthcare sector company. As of July 24, 2026, KNSA trades at $63.35 with a market cap of $4.80B and a P/E ratio of 64.02. KNSA moved +0.78% today. Year to date, KNSA is +52.85%; over the trailing twelve months it is +132.49%. Its 52-week range spans $17.82 to $67.53. Analyst consensus is strong buy with an average price target of $68.29. Rallies surfaces KNSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for KNSA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $63.35 |
| Market Cap | $4.80B |
| P/E Ratio | 64.02 |
| EPS | $0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $67.53 |
| 52-Week Low | $17.82 |
| Volume | 248.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $754.04M |
| Net Income | $73.06M |
| Gross Margin | 89.31% |
7 analysts cover KNSA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $68.29.